Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Recruiting 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Neoplasm Metastasis 3Multiple Myeloma 3Glioma 3Glioblastoma 3Endometrial Neoplasms 3Diffuse Intrinsic Pontine Glioma 3Triple Negative Breast Neoplasms 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Unspecified Adult Solid Tumor 1Solid Tumors 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Obesity 1Neuroendocrine Tumors 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Gliosarcoma 1Fallopian Tube Neoplasms 1Endometrial Cancer Recurrent 1Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinosarcoma 1Breast Neoplasms, Male 1Advanced Glioblastoma 1

Interventions

Temozolomide 15Radiotherapy 11Everolimus 6Bevacizumab 6Irinotecan 5Cyclophosphamide 5ribociclib 4Radiation 4Panobinostat 4TIC10 compound 3Specimen Handling 3Re-Irradiation 3Etoposide 3Dasatinib 3pembrolizumab 2nimotuzumab 2abemaciclib 2Vorinostat 2Valproic Acid 2Topotecan 2Nivolumab 2Mebendazole 2Magnetic Resonance Spectroscopy 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gemcitabine 2GDC-0084 2Erlotinib Hydrochloride 2Diphtheria-Tetanus Vaccine 2Cilengitide 2Cetuximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Diffuse Intrinsic Pontine Glioma × TIC10 compound × Clear all
NCT05476939 2026-02-05

BIOMEDE 2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
433 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

NCT05009992 2025-12-17

PNOC022

University of California, San Francisco

Phase 2 Recruiting
360 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

NCT03416530 2025-02-14

ONC201 in Pediatric H3 K27M Gliomas

Jazz Pharmaceuticals

Phase 1 Terminated
134 enrolled 1 FDA
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡